GenMont Biotech Incorporation (3164.TW) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About GenMont Biotech Incorporation
—
GenMont Biotech Incorporation is led by CEO Yu Chin Chen, employs 147 people, headquartered in Tainan City, TW, publicly traded since 2008.
GenMont Biotech Incorporation (3164.TW) stock trades at $16.80 with a market capitalization of $1.46B. The stock is valued at a price-to-earnings (P/E) ratio of 21.19, price-to-book of 1.11, price-to-sales of 3.82. Over the past 52 weeks the stock has ranged between $15.35 and $19.75, and currently trades 14.9% below its 52-week high. It pays a dividend yielding 4.72%.
On profitability, GenMont Biotech Incorporation generates a return on equity (ROE) of 4.26%, an operating margin of 14.22%, a net profit margin of 18.10%.
Official website: www.genmont.com.tw
GenMont Biotech Incorporation (3164.TW) — frequently asked questions
What is GenMont Biotech Incorporation (3164.TW) stock price today?
GenMont Biotech Incorporation (3164.TW) is currently trading at $16.80, up 0.3% today.
What is 3164.TW P/E ratio?
GenMont Biotech Incorporation's P/E ratio is 21.19. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 3164.TW return on equity (ROE)?
GenMont Biotech Incorporation's return on equity (ROE) is 4.26%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is GenMont Biotech Incorporation's market cap?
GenMont Biotech Incorporation has a market capitalization of $1.46B.
Does 3164.TW pay a dividend?
Yes. GenMont Biotech Incorporation currently yields 4.72%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 3164.TW carry?
GenMont Biotech Incorporation has a debt-to-equity ratio of 0.09. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 3164.TW's profit margin?
GenMont Biotech Incorporation reports a net profit margin of 18.10% — the share of revenue left after every cost, including tax and interest.
What sector is 3164.TW in?
GenMont Biotech Incorporation is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 3164.TW listed on?
GenMont Biotech Incorporation trades on TAI under the ticker 3164.TW.
What is 3164.TW's 52-week range?
Over the last year GenMont Biotech Incorporation has traded between $15.35 and $19.75.
Related — Stocks
Popular Stocks
Screens 3164.TW currently matches
On the figures above, GenMont Biotech Incorporation passes the filters for 15 of our ready-made screens, among them High Dividend Stocks, Dividend Stocks, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.